Hirata Joins MS&L to Lead Healthcare in Japan
Charting the future of public relations
Holmes Report
CEO

Hirata Joins MS&L to Lead Healthcare in Japan

MS&L has appointed Ken Hirata as director of healthcare in its Japan office. In his new role, Hirata will oversee MS&L Japan’s healthcare accounts, including sanofi-aventis, AstraZeneca and AMD Alliance International.

Paul Holmes

TOKYO—MS&L has appointed Ken Hirata as director of healthcare in its Japan office. In his new role, Hirata will oversee MS&L Japan’s healthcare accounts, including sanofi-aventis, AstraZeneca and AMD Alliance International.  He will also focus on growing the office’s healthcare practice, and will work on recruiting and training programs to help develop staff expertise in the healthcare and pharmaceutical sectors.

Hirata, who has more than 20 years of communications experience in the pharmaceutical industry, was most recently senior healthcare consultant with Burson-Marsteller Tokyo. Prior to that, he worked at Eli Lilly Japan for more than 10 years in its corporate affairs group, where he was responsible for product, corporate, advocacy and crisis/risk management communications, as well as other external communications. He also directed and managed several key product launches in the therapeutic areas of oncology, psychiatry, osteoporosis and endocrinology.

Prior to his role at Eli Lilly, Hirata was with The Japan Upjohn Company and Pharmacia & Upjohn Company for nearly 10 years, responsible for crisis management, product marketing support and corporate communications.

View Style:

Load 3 More
comments powered by Disqus